FIELD: medicine. SUBSTANCE: method involves subconjunctivally administering medical preparation into the region of conjunctiva segment. Preventive transconjunctival cryogenic applications or laser coagulation of sclera and flap part of ciliary body are carried out in this segment. EFFECT: higher concentration of drug in the posterior eye segment. 3 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ADMINISTERING MEDICAMENTS WHEN TREATING POSTERIOR EYE SEGMENT DISEASES | 2002 |
|
RU2199988C1 |
METHOD FOR TRANSCHOROID INTRODUCTION OF MEDICINAL PREPARATIONS AT DYSTROPHIC DISEASES OF POSTERIOR OCULAR DEPARTMENT | 2005 |
|
RU2281735C1 |
METHOD FOR TREATING GLAUCOMA | 1999 |
|
RU2149616C1 |
METHOD FOR TREATING RETINA AND OPTIC NERVE DISEASES OF DYSTROPHIC GENESIS | 2002 |
|
RU2199989C1 |
METHOD OF TREATING UNSTABILISED INITIAL GLAUCOMA | 2011 |
|
RU2464000C1 |
METHOD OF TREATING INVOLUTIONAL EYE DISEASES | 2011 |
|
RU2565840C2 |
METHOD FOR TREATING IRIS AND CILIARY BODY INFLAMMATION STATES ACCOMPANIED BY FIBRINOUS EXUDATION | 2001 |
|
RU2192227C1 |
MULTIMODALITY THERAPY OF PRIMARY OPEN-ANGLE GLAUCOMA AND CATARACT | 2008 |
|
RU2380072C1 |
METHOD FOR TREATING GLAUCOMATOUS NEUROPATHY | 2006 |
|
RU2308916C1 |
METHOD FOR REVEALING NOT VISUALIZED FIBRINOUS EXUDATE IN THE MOISTURE OF THE FORWARD CHAMBER OF THE EYE | 2005 |
|
RU2297857C2 |
Authors
Dates
2000-05-27—Published
1999-11-10—Filed